Death from myocardial infarction was a rare clinical entity at the beg
inning of this century, but with an ageing population it is poised to
become the most common cause of death worldwide.(1) Ample epidemiologi
cal evidence confirms the clinical impression that cardiovascular risk
factors-hypertension, glucose intolerance, dyslipidaemia, obesity-ten
d to 'cluster' in individual patients.(2) This metabolic syndrome, or
'Syndrome X', which is thought to be underpinned by decreased insulin
sensitivity, was first described in 1966 by Camus(3) and popularized b
y Reaven in 1988.(4) The enthusiasm and interest generated have led to
the elucidation of some details concerning the pathogenesis of insuli
n resistance and coronary artery disease but have done little to chang
e treatments or outcomes. Meanwhile, a global epidemic of Type 2 diabe
tes mellitus is said to be on the horizon(5) and it has been calculate
d that by the year 2230, 100 % of the adult United States population w
ill be obese.(6) (C) 1998 John Wiley & Sons, Ltd.